CLSI GP47 (R2019)

CLSI GP47 (R2019)

Click here to purchase
This guideline provides current best practice recommendations for developing and implementing a policy and procedures for the identification, reporting, and management of critical- and significant-risk laboratory results. Emphasis is placed on management responsibilities such as development of the policy, the process, procedures, job descriptions, and monitoring systems that ensure effective reporting and compliance with regulatory requirements.

Executive Summary
This is an executive summary of GP47–Management of Critical- and Significant-Risk Results. It provides a compilation of all key recommendations from GP47 for policies and processes as well as risk management principles and information technology for the management of laboratory results that indicate critical or significant risk to patients.

Product Details

Published:
12/01/2015
ISBN(s):
156238919X
Number of Pages:
112
File Size:
2 files , 7.2 MB

You may also like

CLSI VET01S

CLSI VET01S

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 6th Edition, VET01SEd6Estandard by Clinical and...

CLSI EP33

CLSI EP33

Use of Delta Checks in the Medical Laboratory, 2nd Edition, EP33Ed2Estandard by Clinical and Laboratory Standards Institute, 06/01/2023

CLSI EP25-Ed2

CLSI EP25-Ed2

Evaluation of Stability of In Vitro Medical Laboratory Test Reagents, 2nd Edition, EP25Ed2Estandard by Clinical and Laboratory Standards Institute, 04/26/2023

CLSI PRE04

CLSI PRE04

Handling, Transport, Processing, and Storage of Blood Specimens for Routine Laboratory Examinations, 1st Edition, PRE04Ed1Estandard by Clinical and Laboratory Standards...

Back to Top